Adipose - Derived Regenerative Cells Improve Cardiac Functional Capacity at 18 Months in Chronic
Ischemic Heart Disease Patients; Statistically Significant Improvement in MVO2 Reported by Cytori at American Heart Association (November, 2010).
Although medical and surgical treatments available today for
the ischemic heart disease patients diminish the risk of acute myocardial infarction and reduce to some extent the incidence of recurrent heart attack, one of the unsolved challenges is to affect myocardium remodeling occurring during ischemic heart failure.
Not exact matches
Through shortened
patient examination times, higher
patient throughput, and lower cost per MRI examination, EPI may become a powerful tool for early diagnosis of some common and potentially treatable
diseases such as
ischemic heart disease, stroke, and cancer.
The Cardiothoracic Surgical Trials Network (CTSN) is reporting results for the first time from a clinical trial of
patients who have a complication of coronary
heart disease known as moderate
ischemic mitral regurgitation (IMR).
The study showed that
patients who held their breath during radiation therapy had only a 1.4 percent rate of
ischemic heart disease after 8 years of follow up and an estimated rate of 3.6 percent after 10 years.
The researchers identified a cohort of 7,704 RA
patients from the Swedish Biologics Register with no previous incidence of
ischemic heart disease who started their first TNF inhibitor between 2001 and 2010.
Dr. Anne, together with first author Harriet Eldredge - Hindy, M.D., showed that this same cohort of
patients will likely have a reduced risk of
ischemic heart disease after 10 years.
Dr. Srivastava has co-founded a biotechnology company to help find new cures for many human
diseases and one of the developmental genes whose role he discovered, Thymosin β4, is currently in clinical trials for
patients suffering
ischemic damage to the
heart.
He found 10 percent of the African - American
patients suffered from atherosclerotic cardiovascular
disease — defined as a
heart attack,
ischemic heart disease, angina, coronary artery
disease or atherosclerotic
disease of any artery.
Current medical literature shows that adult stem cell therapy, on which the Okyanos protocol is patterned, is safe and suggests a beneficial effect on
patients with
ischemic heart disease.
Yet another study was conducted on a group of
patients who have
ischemic heart disease.
(4) A randomized controlled trial included
patients with either
ischemic heart disease, glucose intolerance, or type 2 diabetes.
Daily Activities and Sleep Durations of
Patients with
Ischemic Heart Disease Who Were Discharged to Their Homes after Elective Percutaneous Coronary Intervention